US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ARK Genomic Revolution ETF

46.93

-0.7100-1.49%

Volume:2.45M

Turnover:114.42M

Market Cap:2.01B

PE:- -

High:47.28

Open:47.18

Low:46.13

Close:47.64

52wk High:50.54

52wk Low:24.20

Shares:42.75M

Float Shares:42.75M

Volume Ratio:0.50

T/O Rate:5.74%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Tanabe Consulting Group Outlines Q1 Results and Long-Term Strategy

Business Engineering Corp Outlines FY2026 1Q Results and AI Growth Strategy

KLab Releases FY2026 Q2 Presentation, Emphasizes Uncertainty in Outlook

Tempus AI (TEM) After CellCarta Deal And PRISM2 Validation Faces A Fresh Valuation Test

Simply Wall St.

Wood: Job Data Doesn't Signal Recession, AI Is Driving the U.S. Into a New Cycle of Deflation and High Productivity

Why Tempus AI (TEM) Is Up 18.6% After Joining CellCarta’s CDx Commercialization Lab Network

Simply Wall St.

10x Genomics (TXG) Stock Rally Leans On Margin Gains And Cash

Simply Wall St.

Bonterra Launches Tradable Rights Offering to Fund Share Issuance

MYR Group Highlights Growth and Strategic Positioning

LCNB Highlights Investor Presentation Under Regulation FD Disclosure

Absci Files Form 3 for CMO, Head of R&D Somaratne Ransi Mudalinayake

Twist Bioscience Chief Legal Officer Dennis Cho Sells 14,205 Shares for $1.56 Million

Absci Corp Expected to Post a Loss of 20 Cents a Share - Earnings Preview

10x Genomics is Maintained at Equal-Weight by Morgan Stanley

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and 10x Genomics (TXG)

Press Release: CANN-is Capital CORP. SIGNS Definitive Agreement with Exiteam Capital Partners LTD. and QUARK Investments LTD.

Analysts Are Bullish on These Healthcare Stocks: Becton Dickinson (BDX), 10x Genomics (TXG)

Ship Healthcare Releases Q1 FY2026 Financial Results Briefing Materials

Yossix Holdings Outlines Structure of Q1 FY2026 Financial Disclosure

Sanoh Industrial Details FY2027 First‑Quarter Financial Performance

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/ARKG/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARKG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARKG\",,,,,undefined,":{"symbol":"ARKG","market":"US","secType":"STK","nameCN":"ARK Genomic Revolution ETF","latestPrice":46.93,"timestamp":1788204467057,"preClose":47.64,"halted":0,"volume":2452716,"delay":0,"changeRate":-0.014903442485306484,"floatShares":42750000,"shares":42750000,"eps":0,"marketStatus":"Trading","change":-0.71,"latestTime":"08-31 15:27:51 EDT","open":47.18,"high":47.28,"low":46.125,"amount":114420317.38578,"amplitude":0.024244,"askPrice":46.95,"askSize":205,"bidPrice":46.94,"bidSize":70,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788206400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"CBOE","adjPreClose":47.64,"sharesOutstanding":39900000,"nav":49.847391,"aum":2041966154.75,"bidAskSpread":0.00024,"preHourTrading":{"tag":"盘前","latestPrice":46.99,"preClose":47.64,"latestTime":"09:29 EDT","volume":2595,"amount":122326.78451999999,"timestamp":1788182999999,"change":-0.65,"changeRate":-0.013644,"amplitude":0.013644},"postHourTrading":{"tag":"盘后","latestPrice":47.5673,"preClose":47.64,"latestTime":"19:53 EDT","volume":7917,"amount":376887.7414,"timestamp":1787961236204,"change":-0.0727,"changeRate":-0.001526,"amplitude":0.019102},"volumeRatio":0.495547,"impliedVol":0.4985,"impliedVolPercentile":0.4064},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARKG\",,,,,undefined,":{"symbol":"ARKG","floatShares":42750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.495547,"shares":42750000,"dividePrice":0,"high":47.28,"amplitude":0.024244,"preClose":47.64,"low":46.125,"week52Low":24.2,"pbRate":"--","week52High":50.535,"institutionHeld":0,"latestPrice":46.93,"committee":-0.490909,"eps":0,"divideRate":0,"volume":2452716,"delay":0,"ttmEps":0,"open":47.18,"prevYearClose":28.97,"prevWeekClose":47.64,"prevMonthClose":38.56,"prevQuarterClose":42.06,"fiveDayClose":48.01,"twentyDayClose":39.62,"sixtyDayClose":36.27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARKG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-12-29","symbol":"ARKG","amount":0.38239,"defaultRemindTime":1640788200000,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000},{"market":"US","date":"2020-12-29","symbol":"ARKG","amount":0.36456,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2020-12-31","payableDate":"2020-12-30","currency":"USD","type":"dividend","dateTimestamp":1609218000000},{"market":"US","date":"2019-12-27","symbol":"ARKG","amount":1.05395,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2019-12-31","payableDate":"2019-12-30","currency":"USD","type":"dividend","dateTimestamp":1577422800000},{"market":"US","date":"2018-12-27","symbol":"ARKG","amount":0.26999,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2018-12-31","payableDate":"2018-12-28","currency":"USD","type":"dividend","dateTimestamp":1545886800000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARKG\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2018-12-31","value":0.26999,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":1.05395,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.36456,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":0.38239,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARKG\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARKG\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658608602","title":"Tanabe Consulting Group Outlines Q1 Results and Long-Term Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658608602","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658608602?lang=en_us&edition=fundamental","pubTime":"2026-08-10 12:23","pubTimestamp":1786335810,"startTime":"0","endTime":"0","summary":"The latest announcement is out from TANABE CONSULTING GROUP CO. LTD ( ($JP:9644) ). Tanabe Consulting Group released supplementary materials for it...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tanabe-consulting-group-outlines-q1-results-and-long-term-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tanabe-consulting-group-outlines-q1-results-and-long-term-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4544","ARKG","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658560412","title":"Business Engineering Corp Outlines FY2026 1Q Results and AI Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658560412","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658560412?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:23","pubTimestamp":1786332233,"startTime":"0","endTime":"0","summary":"Business Engineering Corporation ( ($JP:4828) ) just unveiled an update. Business Engineering Corporation released briefing materials for its first...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/business-engineering-corp-outlines-fy2026-1q-results-and-ai-growth-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/business-engineering-corp-outlines-fy2026-1q-results-and-ai-growth-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIX","BK4585","CHAT","VTHR","BK4544","AIPO","BK4588","ARTY","QTOC","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658604105","title":"KLab Releases FY2026 Q2 Presentation, Emphasizes Uncertainty in Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2658604105","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658604105?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:22","pubTimestamp":1786332170,"startTime":"0","endTime":"0","summary":"KLab Inc. ( ($JP:3656) ) has issued an announcement. KLab Inc. has released its presentation materials for the second quarter of fiscal year 2026, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/klab-releases-fy2026-q2-presentation-emphasizes-uncertainty-in-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/klab-releases-fy2026-q2-presentation-emphasizes-uncertainty-in-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","BK4544","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658670176","title":"Tempus AI (TEM) After CellCarta Deal And PRISM2 Validation Faces A Fresh Valuation Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2658670176","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658670176?lang=en_us&edition=fundamental","pubTime":"2026-08-10 00:30","pubTimestamp":1786293017,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) is back in focus after CellCarta added the company to its CDx Commercialization Lab Network, linking Tempus Hub ordering to CellCarta testing and tightening access to oncology companion diagnostics for U.S. providers.\nSee our latest analysis for Tempus AI.\nTempus AI’s recent CellCarta partnership, PRISM2 publication and earnings update have arrived alongside a sharp 1-day share price return of 12.86% and a 7-day share price return of 18.65%. However, the year-to-date share...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-after-cellcarta-deal-and-prism2-validation-fac","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-after-cellcarta-deal-and-prism2-validation-fac","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","ARKG","TEMT","BK4611","LU1861559042.SGD","HEAL","BK4613","LU1861558580.USD","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169023813","title":"Wood: Job Data Doesn't Signal Recession, AI Is Driving the U.S. Into a New Cycle of Deflation and High Productivity","url":"https://stock-news.laohu8.com/highlight/detail?id=1169023813","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169023813?lang=en_us&edition=fundamental","pubTime":"2026-08-09 22:30","pubTimestamp":1786285839,"startTime":"0","endTime":"0","summary":"Cathie Wood, founder of the renowned investment firm ARK Invest, stated on the 8th that recent U.S. employment data, which has sparked market concerns, actually masks deeper structural economic...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLTW","BITY","BITU","CBTY","BK4550","USHY","ARKK","BBSB","DRN","CBXJ","XBTY","CBOA","SGOV","IEI","XLRE","BK4585","BTF","GBTC","SCHO","NCPB","SBIT","CBTJ","DRV","TYO","CBXA","BETH","BOND","ISHG","BK4594","ARKB","GBIL","ARKF","BTRN","SHV","BTFX","TLT","BK4588","ARKW","BSV","BITX","PBDC","ARKG","XLRI","DBA","IGOV","FBTC","BBIB","CIVG","BWZ","TLTX","TBJL","TBT","CBOJ","EDV","GOLY","CGUS","IBIT","QBF","MUNX","BITI","XLP","BTCZ","BFAP","IYR","ITB","BK4601","VDC","ARKQ","BTCI","TBIL","TFJL","SHY","CBTA","TSYW","ARKX","CBOY","TLH","DEFI","FLGV","BCCC","ARTY","BWX","HODL","BAGY","VCIT","CBXO","ZVOL","BTC","MNRS","BTCW","AGIX","BBLB","BK4535","AIPO","YBTC","IEF","CBTO","CHAT","GOVT","SARK","TLTI","ZROZ","MAXI","QTOC","BRRR","BETE","VGLT","BTCL","VTHR","CBXY","XHB","MINT","BTCC","BFJL","NAIL","XRT","BPI","BK4544","UBT","VCSH","BTCO","BITO","BITB","CBOO","EZBC","SCHH","DBND","DFII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657845678","title":"Why Tempus AI (TEM) Is Up 18.6% After Joining CellCarta’s CDx Commercialization Lab Network","url":"https://stock-news.laohu8.com/highlight/detail?id=2657845678","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657845678?lang=en_us&edition=fundamental","pubTime":"2026-08-08 20:31","pubTimestamp":1786192260,"startTime":"0","endTime":"0","summary":"On 6 August 2026, CellCarta Inc. said it would add Tempus AI to its CDx Commercialization Lab Network, with Tempus using its Tempus Hub to manage provider test ordering, sample routing to CellCarta, and result delivery for oncology-focused companion diagnostics in the U.S.\nThis collaboration links Tempus AI’s ordering and data platform with CellCarta’s development and regulatory capabilities, aiming to close the gap between CDx approval and real-world clinical access for cancer...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/why-tempus-ai-tem-is-up-186-after-joining-cellcartas-cdx-com","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/why-tempus-ai-tem-is-up-186-after-joining-cellcartas-cdx-com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HEAL","ARKG","BK4613","BK4121","LU1861558580.USD","LU1861559042.SGD","TEMT","TEM","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657419624","title":"10x Genomics (TXG) Stock Rally Leans On Margin Gains And Cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2657419624","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657419624?lang=en_us&edition=fundamental","pubTime":"2026-08-08 07:46","pubTimestamp":1786146379,"startTime":"0","endTime":"0","summary":"10x Genomics stock jumped 14.1% to about US$52 after its Q2 report, and the move appears to reflect sentiment rather than a sudden profit breakthrough. The company still reported a loss per share and quarterly revenue of US$151 million, so the market is effectively reacting to the quality of the loss, not the absence of it.\nThe key focus for traders is margin and balance sheet resilience. Gross margin improved to roughly 74%, and cash and marketable securities stood at US$552 million. Today’s...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/10x-genomics-txg-stock-rally-leans-on-margin-gains-and-cash","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/10x-genomics-txg-stock-rally-leans-on-margin-gains-and-cash","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TXG","BK4121","LU1861559042.SGD","LU1861558580.USD","BK4548","FMED","BK4588","BK4585","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657862181","title":"Bonterra Launches Tradable Rights Offering to Fund Share Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2657862181","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657862181?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:39","pubTimestamp":1786138788,"startTime":"0","endTime":"0","summary":"BonTerra Resources ( ($TSE:BTR) ) has shared an announcement. Bonterra Resources has mailed materials for its previously announced rights offering ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bonterra-launches-tradable-rights-offering-to-fund-share-issuance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bonterra-launches-tradable-rights-offering-to-fund-share-issuance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4544","BK4585","ARKG","BTR","BK4588","CLM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657629242","title":"MYR Group Highlights Growth and Strategic Positioning","url":"https://stock-news.laohu8.com/highlight/detail?id=2657629242","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657629242?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:20","pubTimestamp":1786137658,"startTime":"0","endTime":"0","summary":"MYR Group ( ($MYRG) ) has issued an announcement. On August 7, 2026, MYR Group Inc. published updated investor presentation materials outlining its...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/myr-group-highlights-growth-and-strategic-positioning?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/myr-group-highlights-growth-and-strategic-positioning?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","BK4544","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657296486","title":"LCNB Highlights Investor Presentation Under Regulation FD Disclosure","url":"https://stock-news.laohu8.com/highlight/detail?id=2657296486","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657296486?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:57","pubTimestamp":1786136257,"startTime":"0","endTime":"0","summary":"LCNB ( ($LCNB) ) just unveiled an announcement. LCNB Corp. disclosed that it plans to use materials identified as Exhibit 99.1 in upcoming meetings...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lcnb-highlights-investor-presentation-under-regulation-fd-disclosure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lcnb-highlights-investor-presentation-under-regulation-fd-disclosure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCNB","BK4544","BK4585","ARKG","BK4211","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657293016","title":"Absci Files Form 3 for CMO, Head of R&D Somaratne Ransi Mudalinayake","url":"https://stock-news.laohu8.com/highlight/detail?id=2657293016","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657293016?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:54","pubTimestamp":1786136059,"startTime":"0","endTime":"0","summary":"Absci files Form 3 for CMO, Head of R&D Somaratne Ransi MudalinayakeAbsci filed an initial beneficial ownership statement for Somaratne Ransi Mudalinayake, chief medical officer, head of R&D.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Absci Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 07, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL3XZzYr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABSI","BK4539","BK4121","ARKG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657626899","title":"Twist Bioscience Chief Legal Officer Dennis Cho Sells 14,205 Shares for $1.56 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657626899","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657626899?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:06","pubTimestamp":1786133192,"startTime":"0","endTime":"0","summary":"Twist Bioscience Chief Legal Officer Dennis Cho sells 14,205 shares for $1.56 millionTwist Bioscience SVP, Chief Legal Officer, Corporate Secretary Dennis Cho sold 14,205 common shares on Aug. 5, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL2Xlktj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience Chief Legal Officer Dennis Cho Sells 14,205 Shares for $1.56 Million","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","ARKG","GNOM","TWST","IDNA","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657625771","title":"Absci Corp Expected to Post a Loss of 20 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657625771","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657625771?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:02","pubTimestamp":1786132945,"startTime":"0","endTime":"0","summary":"Absci Corp <ABSI.OQ> expected to post a loss of20cents a share - Earnings PreviewAbsci CorpABSI.OQABSI.Ois expected to  show a rise in quarterly revenue when it reports  results on August 11 for the p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4442GN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ARKG","BK4139","BK4539","ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657862380","title":"10x Genomics is Maintained at Equal-Weight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2657862380","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657862380?lang=en_us&edition=fundamental","pubTime":"2026-08-08 02:27","pubTimestamp":1786127220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TXG/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","BK4548","BK4121","LU1861559042.SGD","BK4585","BK4588","FMED","ARKG","TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657362873","title":"Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and 10x Genomics (TXG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657362873","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657362873?lang=en_us&edition=fundamental","pubTime":"2026-08-08 02:00","pubTimestamp":1786125646,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Verrica Pharmaceuticals (VRCA) and 10x Genomics (TXG). Verrica Ph...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","VRCA","LABU","BK4121","BK4581","HCSG","BK4585","ARKG","BK4137","LU1861558580.USD","LU1861559042.SGD","LU0029874061.USD","BK4588","TXG","XBI","XLV","FMED","BK4548","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657640250","title":"Press Release: CANN-is Capital CORP. SIGNS Definitive Agreement with Exiteam Capital Partners LTD. and QUARK Investments LTD.","url":"https://stock-news.laohu8.com/highlight/detail?id=2657640250","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657640250?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:49","pubTimestamp":1786121340,"startTime":"0","endTime":"0","summary":"outstanding convertible loans of Exiteam (the \"Exiteam Convertible Loans. may be converted, in accordance with their terms, into ordinary shares. Shares, and the issued and outstanding shares of Quark (the \"Quark","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKX","ARKF","ARKG","BK4544","SARK","BK4585","91013","CORP","CANN","BK4588","ARKQ","BK4123","BK4165","ARKK","BK4550","ARKW","91512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657646498","title":"Analysts Are Bullish on These Healthcare Stocks: Becton Dickinson (BDX), 10x Genomics (TXG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657646498","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657646498?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:00","pubTimestamp":1786107618,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Becton Dickinson (BDX), 10x Genomics (TXG) and Steri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-becton-dickinson-bdx-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-becton-dickinson-bdx-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1894683264.USD","LU0072461881.USD","BK4585","LU1571399168.USD","BK4548","LU0433182093.SGD","LU0068578508.USD","LU0006061336.USD","LU1894683348.USD","LU0289739343.SGD","TXG","LU0162691827.USD","LU1201861165.SGD","ARKG","LU1854104046.USD","IHI","BK4504","FMED","LU1059921491.USD","LU1861559042.SGD","LU0648000940.SGD","BK4082","LU0985489474.SGD","IE00BFXG1179.USD","BK4121","LU0985320562.USD","LU1489326972.SGD","BK4588","LU0266013472.USD","LU0511384066.AUD","LU0878866978.SGD","BDX","LU0130103400.USD","LU0289961442.SGD","LU1861558580.USD","LU1150488218.USD","LU0130518102.USD","LU1150488135.SGD","LU1854103824.USD","LU0477156797.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657984612","title":"Ship Healthcare Releases Q1 FY2026 Financial Results Briefing Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2657984612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657984612?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:20","pubTimestamp":1786098005,"startTime":"0","endTime":"0","summary":"An update from Ship Healthcare Holdings ( ($JP:3360) ) is now available. Ship Healthcare Holdings, Inc. released materials for its consolidated fin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ship-healthcare-releases-q1-fy2026-financial-results-briefing-materials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ship-healthcare-releases-q1-fy2026-financial-results-briefing-materials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4544","BK4581","LABU","XLV","BK4588","XBI","ARKG","HCSG","UYM","BK4585","LU0128526141.USD","LU0029874061.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657988612","title":"Yossix Holdings Outlines Structure of Q1 FY2026 Financial Disclosure","url":"https://stock-news.laohu8.com/highlight/detail?id=2657988612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657988612?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:18","pubTimestamp":1786097915,"startTime":"0","endTime":"0","summary":"Yossix Holdings Co.Ltd. ( ($JP:3221) ) has shared an announcement. Yossix Holdings Co.,Ltd. released materials related to its first-quarter consoli...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yossix-holdings-outlines-structure-of-q1-fy2026-financial-disclosure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yossix-holdings-outlines-structure-of-q1-fy2026-financial-disclosure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4544","BK4585","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657407614","title":"Sanoh Industrial Details FY2027 First‑Quarter Financial Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2657407614","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657407614?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:59","pubTimestamp":1786096774,"startTime":"0","endTime":"0","summary":"Sanoh Industrial Co., Ltd. ( ($JP:6584) ) has shared an announcement. Sanoh Industrial Co., Ltd. has released explanatory materials for the first q...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sanoh-industrial-details-fy2027-firstquarter-financial-performance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sanoh-industrial-details-fy2027-firstquarter-financial-performance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ARKG","BK4544","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}